MedTrace Logo

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

NCT00897910 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2016-01-11

Study results available
· View outcomes & findings →

Summary

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about T cells and plan better treatment for multiple myeloma.

PURPOSE: This research study is looking at T cells in blood and bone marrow samples from patients with multiple myeloma.

Conditions

  • Multiple Myeloma and Plasma Cell Neoplasm

Interventions

OTHER

flow cytometry

Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.

OTHER

immunoenzyme technique

Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.

OTHER

laboratory biomarker analysis

Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Barbara Ann Karmanos Cancer Institute

    lead OTHER

Principal Investigators

  • Zaid Al-Kadhimi, MD · Barbara Ann Karmanos Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-11-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897910 on ClinicalTrials.gov